Porcine Reproductive and Respiratory Syndrome is one of the most devastating global swine diseases.

The US Food and Drug Administration announced on April 30, 2025  it has granted approval to PIC for the gene edit used in its PRRS-resistant pig, determining that the technology is safe and effective.

This is a landmark approval, as PIC becomes among the first companies to gain approval for gene editing in commercial livestock in the US.